BRAF and colorectal carcinoma: No differences in gender, age (including the incidence of early-onset CRC compared to average-onset CRC), ECOG-PS, sidedness, RAS/BRAF mutational status, treatment with radiotherapy, and inclusion in clinical trials across years were found.